Ikaria, Inc. announced today that its INOMAX« DS drug-delivery systems inthe United States are being voluntarily recalled due to the potential failure of a pressure switch which mayhave an impact on the administration of INOMAX« (nitric oxide) for inhalation to patients. This potentialfailure was identified by Ikaria as part of its ongoing quality monitoring and review processes. This class Irecall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

Read More...